Health Condition 1: D67- Hereditary factor IX deficiency Health Condition 2: D66- Hereditary factor VIII deficiency
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
St. Johns Medical College Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Male or female participants diagnosed with Haemophilia A or B, with or without inhibitors confirmed by laboratory assays factor eight or nine deficiency. Participants of all ages paediatric and adult. Currently receiving either prophylaxis therapy or episodic therapy for at least 6 months prior to enrolment. Willingness and ability to provide informed consent. If the participant is a minor consent will be obtained from the legal guardian and assent from the minor if appropriate. Availability of medical records for the past six months to confirm the treatment history and clinical status.
Exclusion criteria
Exclusion criteria: Patients with any other coagulopathies von Willebrand disease platelet dysfunction or bleeding disorders. Patients who have undergone major surgery within the past three months and whose post-surgical care could confound study outcomes. Patients unable or unwilling to comply with the study requirements or complete the full twelve month follow up period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is a non-interventional study. Study outcomes include comparison of clinical status of hemophilia patients on prophylaxis therapy versus those on episodic therapy. Timepoint: Baseline Three months, Six months and Twelve months. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Cecil Ross
St. Johns Medical College Hospital
Outcome results
None listed